Asian Medical Device Markets (Medical Devices in China, India, Japan, South Korea and Australia)

 
   Single User - $1,995
   Hard Copy Mail Delivery - $4,395
   Corporate License - $7,990
   Online Download plus 1 Hard Copy - $4,795


Loading...
Published May 1, 2007 | 260 Pages | Pub ID: KLI1432857

Companies seeking increased revenue for their products cannot ignore the Asian Medical Device Market. Although Asia Pacific as a region was the smallest healthcare market out of the three major geographic regions (US, Europe, and Asia Pacific), rising income and with it, continued growth in healthcare spending makes Asia an important market for makers of medical devices. Kalorama Information's Asian Medical Device Markets is your guide to the market for medical devices in 5 key markets:
  • Australia
  • Japan
  • South Korea
  • China
  • India
What countries are the best targets for device maker revenue growth in Asia and why? How are Asian markets structured and what regulations do new entrants need to be aware of? What companies have been successful marketing devices in Asia? What types of products are selling in each country? This report answers these questions and includes:
  • Historical & Current Revenues for Medical Devices in 5 markets.
  • Forecasted Market Size to 2010 for each country.
  • Complete Demand-Side Analysis takes into account purchasing entities and important drivers for growth.
  • Discussion of the types of devices exported and imported by each country.
  • Extensive Background on Asian Healthcare Spending.
  • Key Regulations that will impact Asian device markets and Certifications necessary to compete in this market.
  • Detailed Profiles of companies operating in the Asian Device market.
  • Seven Solid Conclusions serious market-watchers will need to know.
  • Discussion and Current Market Size of the Taiwanese Device Market.
  • Profiles of Major Companies competing in the Asian Device Market.
Information is derived from extensive research of company reports, medical literature, trade publications and government data. But as part of Kalorama's trusted information-gathering process, industry experts are interviewed for their assessment of the market. Asian medical device market trends covered in the report include:
  • Importing/Exporting Trends
  • Demographics Forecasts
  • Healthcare Spending Trends
  • Privatization of Healthcare
  • Regulatory Trends
  • Alliances of Healthcare Companies and Medical Schools
Business development, marketing and sales executives of device manufacturing companies as well as advertising and financial executives serving or investing in medical device companies are among those who will benefit from this report.
Chapter One: Executive Summary
  • 1.1 Healthcare Industry
  • 1.2 Healthcare In Asia
  • 1.3 Definition And Scope
  • 1.4 Medical Devices
  • 1.5 Market Overview
    • 1.5.3 Australia
    • 1.5.2 China
    • 1.5.5 India
    • 1.5.1 Japan
    • 1.5.4 South Korea

  • 1.6 Demand Side Analysis
    • 1.6.3 Australia
    • 1.6.2 China
    • 1.6.5 India2
    • 1.6.1 Japan
    • 1.6.4 South Korea

  • 1.7 Key Regulations And Certifications
    • 1.7.3 Australia
    • 1.7.2 China
    • 1.7.5 India
    • 1.7.1 Japan
    • 1.7.4 South Korea

  • 1.8 Conclusions

Chapter Two: Introduction

  • 2.1 Healthcare Industry
    • 2.1.1 Worldwide Healthcare Market

  • 2.2 Healthcare in Asia
    • 2.2.1 Asia - Healthcare Statistics
    • 2.2.1.1 Healthcare Spending as a Percentage of GDP
    • 2.2.1.2 Per Capita Healthcare Spending
    • 2.2.2 Trends in Asian Healthcare Markets

  • 2.3 Definition and Scope
    • 2.3.1 Definition
    • 2.3.2 Geographical Scope of the Study

Chapter three: Classification of Medical Devices

  • 3.1 Definition
  • 3.2 Classification of Medical Devices
  • 3.3 Categorization of Medical Devices

Chapter four: Market Data & Analysis

  • 4.1 Australia
    • 4.1.1 Market Size
    • 4.1.2 Market Size Projections
    • 4.1.3 Industry Structure
    • 4.1.4 Trends
    • 4.1.4.1 Import-Export Trends
    • 4.1.4.2 Australian Medical Devices - Worldwide Acceptance
    • 4.1.4.3 Medical Devices vs Pharmaceutical Products - Development Cycle
    • 4.1.5 Factors Affecting the Market
    • 4.1.5.1 Growth Drivers
    • 4.1.5.2 Growth Inhibitors

  • 4.2 China
    • 4.2.1 Market Size
    • Taiwan Market
    • 4.2.2 Market Size Projections
    • 4.2.3 Trends
    • 4.2.4 Factors Affecting the Market
    • 4.2.4.1 Growth Drivers
    • 4.2.4.2 Growth Inhibitors

  • 4.3 India
    • 4.3.1 Market Size
    • 4.3.2 Market Size Projections
    • 4.3.3 Trends
    • 4.3.3.1 Import-Export Trends
    • 4.3.3.2 Medical Tourism
    • 4.3.4 Factors Affecting the Market
    • 4.3.4.1 Growth Drivers

  • 4.4 Japan
    • 4.4.1 Market Size
    • 4.4.2 Market Size Projections
    • 4.4.3 Industry Structure
    • 4.4.3.1 Business through General Dealers
    • 4.4.3.2 Business through Specialist Dealers
    • 4.4.3.3 Direct Sales
    • 4.4.4 Trends
    • 4.4.4.1 Import-Export Trends
    • 4.4.4.2 Eldercare Market
    • 4.4.5 Factors Affecting the Market
    • 4.4.5.1 Growth Drivers
    • 4.4.5.2 Growth Inhibitors

  • 4.5 South Korea
    • 4.5.1 Market Size
    • 4.5.2 Market Size Projections
    • 4.5.3 Trends
    • 4.5.3.1 Import-Export Trends
    • 4.5.4 Factors Affecting the Market
    • 4.5.4.1 Growth Drivers
    • 4.5.4.2 Growth Inhibitors

Chapter Five: Demand Side Analysis

  • 5.1 Australia
    • 5.1.1 Demand Side Statistics
    • 5.1.1.1 Increase in the Number of Hospitals and Related Expenditure
    • 5.1.1.2 Statistics Related to Medical Procedures
    • 5.1.2 Demographics
    • 5.1.2.1 Increase in the Number of People Aged 65 Years and Above

  • 5.2 China
    • 5.2.1 Potential Market for Replacement Sales
    • 5.2.2 Higher Demand for Medical Devices from ‘Retirement Homes’
    • 5.2.3 Demand for High-Quality Medical Devices and More Efficient Healthcare Services 
    • 5.2.4 Increased Acceptance of Diagnostic Devices in Taiwan

  • 5.3 India
    • 5.3.1 Public Sector vs Private Sector
    • 5.3.2 Healthcare Infrastructure
    • 5.3.2.1 Government Healthcare Infrastructure
    • 5.3.2.2 Private Healthcare Infrastructure
    • 5.3.3 Demographics
    • 5.3.3.1 Increase in the Number of People Aged 65 Years and Above

  • 5.4 Japan
    • 5.4.1 Demographics
    • 5.4.1.1 Increase in the Number of People Aged 65 Years and Above
    • 5.4.2 Medical Devices Preferences

  • 5.5 South Korea
    • 5.5.1 Modernization of Hospitals
    • 5.5.2 Increasing Demand for Homecare Medical Devices

Chapter Six: Key Regulations and Certifications

  • 6.1 Global Regulatory Bodies
    • 6.1.1 Global Harmonization Task Force (GHTF)
    • 6.1.2 US Food and Drug Administration (US FDA)

  • 6.2 Australia
    • 6.2.1 Regulatory Bodies and Committees
    • 6.2.1.1 Therapeutic Goods Administration (TGA)
    • 6.2.1.2 The Australian Register of Therapeutic Goods (ARTG)

  • 6.3 China
    • 6.3.1 Key Regulations
    • 6.3.2 Regulations and Registrations in Taiwan
    • 6.3.3 Recent Regulatory Changes
    • 6.3.3.1 Medical Devices Testing
    • 6.3.3.2 New Pricing Policy for Medical Devices
    • 6.3.3.3 New Regulation - Medical Devices Quality System Management
    • 6.3.3.4 Registration
    • 6.3.3.5 Supervising Medical Devices Manufacturers

  • 6.4 India
    • 6.4.1 Regulatory Bodies and Committees
    • 6.4.1.1 Indian Medical Devices Regulatory Authority
    • 6.4.1.2 Central Drug Standard Control Organization (CDSCO)

  • 6.5 Japan
    • 6.5.1 Regulations
    • 6.5.1.1 Revision of Medical Devices Approval Applications Classifications
    • 6.5.2 Certifications
    • 6.5.2.1 MHLW Ministerial Ordinance No. 169, 2004
    • 6.5.2.2 MHLW Ministerial Ordinance No. 2, 1961, revised by MHLW Ministerial Ordinance No. 73, 2005  
    • 6.5.2.3 MHLW Ministerial Ordinance No. 136, 2004

  • 6.6 South Korea
    • 6.6.1 Key Regulations
    • 6.6.2 Registrations for Medical Devices Approval
    • 6.6.2.1 Classification of Medical Devices
    • 6.6.2.2 Manufacturing/Importing Approval/Announcement Application
    • 6.6.2.3 Examination of Technical Documents
    • 6.6.2.4 Testing
    • 6.6.2.5 Medical Devices Manufacture/Import and Quality Control Rules

Chapter Seven: Conclusions

  • 7.1 First Conclusion
  • 7.2 Second Conclusion
  • 7.3 Third Conclusion
  • 7.4 Fourth Conclusion
  • 7.5 Fifth Conclusion
  • 7.6 Sixth Conclusion
  • 7.7 Seventh Conclusion

Chapter Eight: Company Profiles

  • 8.1 3M Company
    • 8.1.1 Key Facts
    • 8.1.2 Company Overview
    • 8.1.3 Geographical Presence and Subsidiaries
    • 8.1.4 Product Portfolio
    • 8.1.5 Key Executives
    • 8.1.6 Performance Review
    • 8.1.6.1 Revenue Performance
    • 8.1.6.2 Performance of Business Segments
    • 8.1.6.3 Performance of Geographic Segments
    • 8.1.6.4 Performance of the Healthcare Segment
    • 8.1.7 Company Strategy

  • 8.2 B Braun Melsungen Ag (B. Braun)
    • 8.2.1 Key Facts
    • 8.2.2 Company Overview
    • 8.2.3 Product Portfolio
    • 8.2.4 Key Executives
    • 8.2.5 Key Competitors
    • 8.2.6 Performance Review
    • 8.2.6.1 Revenue Performance
    • 8.2.6.2 Performance of Business Segments
    • 8.2.6.3 Performance of Geographic Segments

  • 8.3 Beijing Wandong Medical Equipment Co., Ltd
    • 8.3.1 Key Facts
    • 8.3.2 Company Overview
    • 8.3.3 Geographical Presence and Business Lines
    • 8.3.4 Product Portfolio
    • 8.3.5 Key Executives
    • 8.3.6 Key Competitors
    • 8.3.7 Performance Review
    • 8.3.7.1 Revenue Performance
    • 8.3.7.2 Performance of Business Segments
    • 8.3.7.3 Performance of Geographic Segments
    • 8.3.8 Company Strategy

  • 8.4 Cochlear Limited
    • 8.4.1 Key Facts
    • 8.4.2 Company Overview
    • 8.4.3 Geographical Presence and Subsidiaries
    • 8.4.4 Product Portfolio
    • 8.4.4.1 Nucleus Freedom Cochlear Implant System
    • 8.4.4.2 Baha System
    • 8.4.5 Key Executives
    • 8.4.6 Performance Review
    • 8.4.6.1 Revenue Performance
    • 8.4.7 Company Strategy

  • 8.5 GE Healthcare Company
    • 8.5.1 Key Facts
    • 8.5.2 Company Overview
    • 8.5.3 Geographical Presence and Business Lines
    • 8.5.4 Product Portfolio
    • 8.5.5 Staff Organization
    • 8.5.7 Key Competitors
    • 8.5.8 Performance Review
    • 8.5.8.1 Revenue Performance
    • 8.5.8.2 Performance of Business Segments
    • 8.5.9 Company Strategy

  • 8.6 Hitachi Medical Corporation
    • 8.6.1 Key Facts
    • 8.6.2 Company Overview
    • 8.6.3 Geographical Presence and Business Lines
    • 8.6.4 Product Portfolio
    • 8.6.5 Organization of Business
    • 8.6.6 Key Executives
    • 8.6.7 Key Competitors
    • 8.6.8 Performance Review
    • 8.6.8.1 Revenue Performance
    • 8.6.8.2 Performance of Business Segments
    • 8.6.8.3 Performance of Geographic Segments

  • 8.7 Johnson & Johnson Co., Ltd
    • 8.7.1 Key Facts
    • 8.7.2 Company Overview
    • 8.7.3 Geographical Presence and Business Lines
    • 8.7.4 Product Portfolio
    • 8.7.5 Staff Organization
    • 8.7.6 Key Executives
    • 8.7.7 Key Competitors
    • 8.7.8 Performance Review
    • 8.7.8.1 Revenue Performance
    • 8.7.8.2 Performance of Business Segments
    • 8.7.8.3 Performance of Geographic Segments
    • 8.7.9 Company Strategy

  • 8.8 Medison Co., Ltd
    • 8.8.1 Key Facts
    • 8.8.2 Company Overview
    • 8.8.3 Geographical Presence and Business Lines
    • 8.8.4 Product Portfolio
    • 8.8.5 Staff Organization
    • 8.8.5.1 Marketing Services
    • 8.8.5.2 Research and Development Services
    • 8.8.5.3 Production Services
    • 8.8.5.4 Administration Services
    • 8.8.6 Key Executives
    • 8.8.7 Key Competitors
    • 8.8.8 Performance Review
    • 8.8.8.1 Revenue Performance
    • 8.8.8.2 Performance of Business Segments
    • 8.8.9 Company Strategy

  • 8.9 Philips Medical Systems Technologies Ltd
    • 8.9.1 Key Facts
    • 8.9.2 Company Overview
    • 8.9.3 Geographic Presence
    • 8.9.4 Product Portfolio
    • 8.9.6 Key Competitors
    • 8.9.7 Performance Review
    • 8.9.7.1 Revenue Performance
    • 8.9.7.2 Performance of Geographic Segments
    • 8.9.8 Company Strategy

  • 8.10 ResMed, Inc.
    • 8.10.1 Key Facts
    • 8.10.2 Company Overview
    • 8.10.4 Product Portfolio
    • 8.10.5 Key Executives
    • 8.10.6 Performance Review
    • 8.10.6.1 Revenue Performance
    • 8.10.6.2 Performance of Geographic Segments
    • 8.10.7 Company Strategy
    • 8.10.7.1 Core Growth Strategies
    • 8.10.7.2 Strategic Acquisitions
    • 8.10.7.3 Global Sales and Marketing
    • 8.1.9.4 Collaboration with Associations

  • 8.11 Siemens Medical Solutions
    • 8.11.1 Key Facts
    • 8.11.2 Company Overview
    • 8.11.3 Geographical Presence and Business Lines
    • 8.11.4 Product Portfolio
    • 8.11.5 Key Executives
    • 8.11.6 Key Competitors
    • 8.11.7 Performance Review
    • 8.11.7.1 Revenue Performance

  • 8.12 Terumo Corporation
    • 8.12.1 Key Facts
    • 8.12.2 Company Overview
    • 8.12.3 Geographical Presence and Business Lines
    • 8.12.4 Product Portfolio
    • 8.12.5 Key Executives
    • 8.12.6 Key Competitors
    • 8.12.7 Performance Review
    • 8.12.7.1 Revenue Performance
    • 8.12.7.2 Performance of Business Segments
    • 8.12.7.3 Performance of Geographic Segments
    • 8.12.8 Company Strategy

  • 8.13 Toshiba Medical Systems Corporation
    • 8.13.1 Key Facts
    • 8.13.2 Company Overview
    • 8.13.3 Geographical Presence and Business Lines
    • 8.13.4 Product Portfolio
    • 8.13.5 Organization of Business
    • 8.13.6 Key Executives
    • 8.13.7 Key Competitors
    • 8.13.8 Performance Review
    • 8.13.8.1 Revenue Performance
    • 8.13.8.2 Performance of Business Segments
    • 8.13.8.3 Performance of Geographic Segments

LIST OF EXHIBITS

Chapter One: Executive Summary

  • Figure 1-1: Expenditure on Healthcare as a Percentage of GDP - Asia (2005-2006)
  • Figure 1-2: Medical Device Categories
  • Figure 1-3: Asian Medical Device Markets (Australia, China, India, Japan,
  • South Korea), 2006-2010

CHAPTER two: Introduction

  • Figure 2-1: Value Chain of the Healthcare Industry
  • Table 2-1: World Population Predictions 2005 and 2050
  • Figure 2-2: Healthcare Spending as a Percentage of GDP - Asia (2005-2010)
  • Figure 2-3: Per Capita Healthcare Spending - Asia (2005-2010)
  • Figure 2-4: Total Healthcare Expenditure Break-up for Asia Pacific (2005)
  • Figure 2-5: Expenditure on Healthcare as a Percentage of GDP - Asia (2005-2006)
  • Figure 2-6: Per Capita Healthcare Spending - Asia (2005-2006)

Chapter three: Classification of Medical Devices

  • Figure 3-1: Medical Device Classification
  • Figure 3-2: Medical Device Categories
  • Figure 3-3: Classification of Surgical Equipment

Chapter four: Market Data & Analysis

  • Table 4-1: Asian Medical Device Market, 5 Key Countries  (Australia, China, India, Japan, South Korea) 2007-2010
  • Figure 4-1: Australian Medical Device market Size (2003-2005)
  • Figure 4-2: Australian Medical Device Market Size - Projection (2007-2010)
  • Figure 4-3: Australian Medical Device market - Segmentation
  • (Diagnostic/Imaging Equipment, Ophthalmic Equipment, Others), 2006
  • Figure 4-4: Australian Medical Device Industry Structure
  • Figure 4-5: Australia - Domestic Production (2004)
  • Figure 4-6: Australia - Domestic Consumption (2004)
  • Figure 4-7: Medical Devices vs Pharmaceutical Products - Development Cycle
  • Figure 4-8: Aging Population - Australia (Age Group 65 Years and above)
  • Figure 4-9: Public Sector vs Private Sector Purchase of Medical Devices - Australia (2005)
  • Figure 4-10: Chinese Medical Device market Size (2000-2006)
  • Figure 4-11: Production Value of Medical Devices in Taiwan (2002-2006)
  • Figure 4-12: Chinese Medical Device market Size - Projection (2005-2010)
  • Figure 4-13: Chinese Medical Device market - Segmentation (IV Diagnostics  Equipment, Disposable Equipment, Ophthalmic Equipment, Others) , 2006 (in USD million) Figure 4-14: Indian Medical Device market Size (1993, 2005-2006)
  • Figure 4-15: Indian Medical Device market Size - Projection (2007-2010)
  • Figure 4-16: Indian Medical Device market - Segmentation (Diagnostic Equipment, Imaging Equipment, Others) 
  • Figure 4-17: India - Domestic Consumption (2004)
  • Figure 4-18: Medical Tourism Industry in India (2006-2012)
  • Figure 4-19: Japanese Medical Device market Size (2000-2006)
  • Figure 4-20: Japanese Medical Device market Size - Projection (2006-2010)
  • Figure 4-21: Japanese Medical Device market - Segmentation (IV Diagnostic
  • Equipment, Disposable Equipment, Ophthalmic Equipment, Others), 2006
  • Figure 4-22: Distribution Patterns for Medical Devices in Japan
  • Figure 4-23: Import and Export of Japanese Medical Devices as a Percent of Market Output (1997-2007)
  • Table 4-2: Population Needing Home Treatment - Forecast (1993-2025)
  • Table 4-3: Average Age of Japan’s Population (1990-2005)
  • Figure 4-24: South Korean Medical Device market Size (2000-2006)
  • Figure 4-25: Medical Devices Manufacturing Market (2000-2006)
  • Figure 4-26: Medical Devices Manufacturing Companies’ Market Share (2004)
  • Figure 4-27: South Korea Medical Device market Size - Projection (2007-2010)
  • Figure 4-28: South Korean Medical Device market - Segmentation
  • (Disposable and Non-Disposable Equipment, 2006
  • Figure 4-29: South Korea Medical Devices Imports (2000-2010)

Chapter Five: Demand Side Analysis

  • Figure 5-1: Public Sector vs Private Sector - Purchase of Medical Devices (2006)
  • Table 5-1: Number of Hospitals (2000-2001 to 2004-2005)
  • Figure 5-2: Number of Public Hospitals vs Private Hospitals - Australia (2005)
  • Table 5-2: Total Recurrent Expenditure from 2000-2001 to 2004-2005
  • Table 5-3: Statistics for Public Hospitals - by Procedure (2004-2005)
  • Table 5-4: Procedure Statistics for Private Hospitals - by Procedure (2004-2005)
  • Figure 5-3: Aging Population - Australia (Age Group of 65 Years and Above)
  • Figure 5-4: Supply-Demand Gap in China’s Medical Device market (2003-2008)
  • Figure 5-5: Healthcare Industry - Public Sector vs Private Sector (2006)
  • Table 5-5: Healthcare Infrastructure in India (2004)
  • Table 5-6: Size of Private Hospitals - Healthcare Units (2004)
  • Table 5-7: Demographics Forecast (2010-2050).
  • Table 5-8: Aging Demographics Forecast (2000-2050)

Chapter Six: Key Regulations and Certifications

  • Figure 6-1: Australian Medical Devices Legislation - Features
  • Figure 6-2: Australian Medical Devices - Route to Market
  • Figure 6-3: Drug and Cosmetics Act - Implementation Framework - Central and State Drug Administrations (CDA)
  • Figure 6-4: Structure of Central Drug Standard Control Organization
  • Table 6-1: Approval, Licensing, and Notification System - Pharmaceutical Affairs Law

Chapter Seven: Conclusions

  • Figure 7-1: Asian Medical Device Markets - Market Attractiveness Chart

Chapter Eight: Company Profiles

  • Table 8-1: Corporate Details of 3M
  • Table 8-2: Geographical Presence and Subsidiaries of 3M
  • Table 8-3: Key Executives of 3M
  • Figure 8-1: 3M Revenue Performance (2001-2006)
  • Figure 8-2: 3M Revenues (by Business Segment) (2006)
  • Figure 8-3: 3M Revenues (by Geography) (2006)
  • Figure 8-4: 3M Revenues (Healthcare Segment) (2004-2006)
  • Table 8-4: Corporate Details of B. Braun
  • Table 8-5: Product Portfolio of B. Braun
  • Table 8-6: Key Executives of B. Braun
  • Figure 8-5: B. Braun Revenue Performance (2004-2005)
  • Figure 8-6: B. Braun Revenues (by Business Segment) (2005)
  • Figure 8-7: B. Braun Revenues (by Geography) (2005)
  • Table 8-7: Corporate Details of Beijing Wandong Medical Equipment
  • Table 8-8: Major Branches and Business Lines of Wandong Medical
  • Table 8-9: Key Executives of Wandong Medical
  • Figure 8-8: Wandong Medical Revenue Performance (2001-2005)
  • Figure 8-9: Wandong Medical Revenues (by Business Segment) (2005)
  • Figure 8-10: Wandong Medical Revenues (by Geography) (2005)
  • Table 8-10: Corporate Details of Cochlear Limited
  • Table 8-11: Geographical Presence and Subsidiaries of Cochlear
  • Table 8-12: Key Executives of Cochlear
  • Figure 8-11: Cochlear Revenue Performance (2001-2006)
  • Figure 8-12: Cochlear Revenues (by Geography) (2006)
  • Figure 8-13: Cochlear Revenue Performance (by Geography) (2004-2006)
  • Table 8-13: Corporate Details of GE Healthcare
  • Table 8-14: Major (Asia Pacific) Operating Locations and Business Lines of GE Healthcare
  • Table 8-15: Key Executives of GE Healthcare
  • Figure 8-14: GE Healthcare Revenue Performance (2002-2006)
  • Figure 8-15: GE Revenues (by Business Segment) (2006)
  • Figure 8-16: GE Income (by Business Segment) (2006)
  • Table 8-16: Corporate Details of Hitachi Medical Corporation
  • Table 8-17: Geographical Presence and Business Lines of Hitachi Medical Corporation
  • Table 8-18: Key Executives of Hitachi Medical Corporation
  • Figure 8-17: Hitachi Medical Corporation Revenue Performance (2004-2006)
  • Figure 8-18: Hitachi Medical Revenue Performance (by Business Segment) (2006)
  • Figure 8-19: Hitachi Medical Revenue Performance (by Geography) (20006)
  • Table 8-19: Corporate Details of Johnson & Johnson
  • Table 8-20: Major Locations and Business Lines of Johnson & Johnson in Asia Pacific
  • Table 8-21: Key Executives of Johnson & Johnson
  • Figure 8-20: Johnson & Johnson Revenue Performance (2002-2006)
  • Figure 8-21: Johnson & Johnson Revenues (by Business Segment) (2006)
  • Figure 8-22: Johnson & Johnson Revenues (by Geography) (2006)
  • Figure 8-23: Medical Devices and Diagnostics Segment Revenues  (by Geography) (2006)
  • Table 8-22: Corporate Details of Medison
  • Table 8-23: Geographical Presence and Business Lines of Medison
  • Table 8-24: Key Executives of Medison
  • Figure 8-24: Medison Revenue Performance (2002-2005)
  • Figure 8-25: Medison Revenues (by Geography) (2005)
  • Table 8-25: Corporate Details of Philips Medical Systems Technologies Ltd
  • Table 8-26: Presence of Philips Medical Systems in Asia Pacific
  • Table 8-27: Key Executives of Philips Medical Systems
  • Figure 8-26: Philips Medical Systems Revenue Performance (2002-2006)
  • Figure 8-27: Philips Medical Systems Revenues (by Geography) (2002-2006)
  • Table 8-28: Corporate Details of ResMed, Inc.
  • Table 8-29: Geographical Presence of ResMed
  • Table 8-30: Product Portfolio of ResMed
  • Table 8-31: Key Executives of ResMed
  • Figure 8-28: ResMed Revenue Performance (2002-2006)
  • Figure 8-29: ResMed Revenues (by Geography) (2006)
  • Table 8-32: Acquisitions of ResMed (1996-2005)
  • Table 8-33: Corporate Details of Siemens Medical Solutions
  • Table 8-34: Geographical Presence and Business Lines of Siemens Medical Solutions 
  • Table 8-35: Key Executives of Siemens Medical Solutions
  • Figure 8-30: Siemens Medical Solutions Revenue Performance (2002-2006)
  • Table 8-36: Corporate Details of Terumo Corporation
  • Table 8-37: Geographical Presence and Business Lines of Terumo Corporation
  • Table 8-38: Key Executives of Terumo
  • Figure 8-31: Terumo Corporation Revenue Performance (2004-2006)
  • Figure 8-32: Terumo Corporation Revenues (by Business Segment) (2006)
  • Figure 8-33: Terumo Corporation Revenues (by Geography) (2006)
  • Table 8-39: Corporate Details of Toshiba Medical Systems Corporation
  • Table 8-40: Geographical Presence and Business Lines of Toshiba Medical Systems Corporation
  • Figure 8-34: Business Divisions of Toshiba Corporation
  • Table 8-41: Key Executives of Toshiba Corporation
  • Figure 8-35: Toshiba Revenue Performance (by Business Segment) (2005)
  • Figure 8-36: Toshiba Revenue Performance (by Geography) (2005)

In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.

We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.